A study on negative and depressive symptom prevalence in individuals at ultra-high risk for psychosis

Early Intervention in Psychiatry

Volumn 12, Issue 5, 2018, Pages 900-906

  Azar, Marleine ^a   Pruessner, Marita ^a,b   Baer, Lawrence H ^a,b   Iyer, Srividya ^a,b   Malla, Ashok K ^a,b   Lepage, Martin ^a,b  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

depression; negative symptoms; primary negative symptoms; ultra high risk for psychosis

Indexed keywords

ADULT; ARTICLE; DEPRESSION; DISEASE DURATION; FEMALE; HIGH RISK POPULATION; HUMAN; ILLNESS TRAJECTORY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; YOUNG ADULT; ADOLESCENT; COMORBIDITY; PRODROMAL SYMPTOM; PSYCHOLOGICAL RATING SCALE; QUEBEC; RISK FACTOR;

ADOLESCENT; ADULT; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; MALE; PREVALENCE; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUEBEC; RISK FACTORS; YOUNG ADULT;

EID: 84992505001     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/eip.12386     Document Type: Article

References (56)

1. Addington, J, Cadenhead, K. S, Cannon, T. D, Cornblatt, B, McGlashan, T. H, Perkins, D. O, … Heinssen, R. (2007). North American Prodrome Longitudinal Study: A collaborative multisite approach to prodromal schizophrenia research. Schizophrenia Bulletin, 33(3), 665–672
2. Addington, J, Van Mastrigt, S, Hutchinson, J, & Addington, D. (2002). Pathways to care: Help seeking behaviour in first episode psychosis. Acta Psychiatrica Scandinavica, 106(5), 358–364
3. an der Heiden, W, Konnecke, R, Maurer, K, Ropeter, D, & Hafner, H. (2005). Depression in the long-term course of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 255(3), 174–184
4. Andreasen, N. C. (1982). Negative symptoms in schizophrenia. Definition and reliability. Archives of General Psychiatry, 39(7), 784–788
5. Arndt, S, Andreasen, N. C, Flaum, M, Miller, D, & Nopoulos, P. (1995). A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Archives of General Psychiatry, 52(5), 352–360
6. Buchanan, R. W. (2007). Persistent negative symptoms in schizophrenia: An overview. Schizophrenia Bulletin, 33(4), 1013–1022
7. Buchy, L, Bodnar, M, Malla, A, Joober, R, & Lepage, M. (2010). A 12-month outcome study of insight and symptom change in first-episode psychosis. Early Intervention in Psychiatry, 4(1), 79–88
8. Carpenter, W. T. Jr, Heinrichs, D. W, & Alphs, L. D. (1985). Treatment of negative symptoms. Schizophrenia Bulletin, 11(3), 440–452
9. Cornblatt, B. A, Carrion, R. E, Addington, J, Seidman, L, Walker, E. F, Cannon, T. D, … Lencz, T. (2012). Risk factors for psychosis: Impaired social and role functioning. Schizophrenia Bulletin, 38(6), 1247–1257
10. Correll, C. U, Hauser, M, Auther, A. M, & Cornblatt, B. A. (2010). Research in people with psychosis risk syndrome: A review of the current evidence and future directions. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 51(4), 390–431
11. Fervaha, G, Foussias, G, Agid, O, & Remington, G. (2014). Impact of primary negative symptoms on functional outcomes in schizophrenia. European Psychiatry: The Journal of the Association of European Psychiatrists, 29(7), 449–445
12. Foussias, G, & Remington, G. (2010). Negative symptoms in schizophrenia: Avolition and Occam's razor. Schizophrenia Bulletin, 36(2), 359–369
13. Fulford, D, Niendam, T. A, Floyd, E. G, Carter, C. S, Mathalon, D. H, Vinogradov, S, … Loewy, R. L. (2013). Symptom dimensions and functional impairment in early psychosis: More to the story than just negative symptoms. Schizophrenia Research, 147(1), 125–131
14. Fusar-Poli, P, Nelson, B, Valmaggia, L, Yung, A. R, & McGuire, P. K. (2014). Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: Impact on psychopathology and transition to psychosis. Schizophrenia Bulletin, 40(1), 120–131
15. Gupta, S, Andreasen, N. C, Arndt, S, Flaum, M, Hubbard, W. C, & Ziebell, S. (1997). The Iowa Longitudinal Study of Recent Onset Psychosis: One-year follow-up of first episode patients. Schizophrenia Research, 23(1), 1–13
16. Hafner, H, Loffler, W, Maurer, K, Hambrecht, M, & an der Heiden, W. (1999). Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica, 100(2), 105–118
17. Hafner, H, Maurer, K, Trendler, G, an der Heiden, W, & Schmidt, M. (2005). The early course of schizophrenia and depression*. European Archives of Psychiatry and Clinical Neuroscience, 255(3), 167–173
18. Hafner, H, Maurer, K, Trendler, G, an der Heiden, W, Schmidt, M, & Konnecke, R. (2005). Schizophrenia and depression: Challenging the paradigm of two separate diseases – A controlled study of schizophrenia, depression and healthy controls. Schizophrenia Research, 77(1), 11–24
19. Heinssen, R. K, Cuthbert, B. N, Breiling, J, Colpe, L. J, & Dolan-Sewell, R. (2003). Overcoming barriers to research in early serious mental illness: Issues for future collaboration. Schizophrenia Bulletin, 29(4), 737–745
20. Hill, S. K, Reilly, J. L, Keefe, R. S, Gold, J. M, Bishop, J. R, Gershon, E. S, … Sweeney, J. A. (2013). Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. The American Journal of Psychiatry, 170(11), 1275–1284
21. Hovington, C. L, Bodnar, M, Joober, R, Malla, A. K, & Lepage, M. (2012). Identifying persistent negative symptoms in first episode psychosis. BMC Psychiatry, 12, 224
22. Hovington, C. L, Bodnar, M, Joober, R, Malla, A. K, & Lepage, M. (2013). Impairment in verbal memory observed in first episode psychosis patients with persistent negative symptoms. Schizophrenia Research, 147(2–3), 223–229
23. Hui, C, Morcillo, C, Russo, D. A, Stochl, J, Shelley, G. F, Painter, M, … Perez, J. (2013). Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis. Schizophrenia Research, 148(1–3), 175–180
24. Kelley, M. E, van Kammen, D. P, & Allen, D. N. (1999). Empirical validation of primary negative symptoms: Independence from effects of medication and psychosis. The American Journal of Psychiatry, 156(3), 406–411
25. Kobayashi, H, Nemoto, T, Murakami, M, Kashima, H, & Mizuno, M. (2011). Lack of association between psychosis-like experiences and seeking help from professionals: A case-controlled study. Schizophrenia Research, 132(2–3), 208–212
26. Koreen, A. R, Siris, S. G, Chakos, M, Alvir, J, Mayerhoff, D, & Lieberman, J. (1993). Depression in first-episode schizophrenia. The American Journal of Psychiatry, 150(11), 1643–1648
27. Lencz, T, Smith, C. W, Auther, A, Correll, C. U, & Cornblatt, B. (2004). Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophrenia Research, 68(1), 37–48
28. Malla, A. K, Norman, R. M, & Joober, R. (2005). First-episode psychosis, early intervention, and outcome: What have we learned? Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 50(14), 881–891
29. Malla, A, & Payne, J. (2005). First-episode psychosis: Psychopathology, quality of life, and functional outcome. Schizophrenia Bulletin, 31(3), 650–671
30. Malla, A. K, Takhar, J. J, Norman, R. M, Manchanda, R, Cortese, L, Haricharan, R, … Ahmed, R. (2002). Negative symptoms in first episode non-affective psychosis. Acta Psychiatrica Scandinavica, 105(6), 431–439
31. Mallinckrodt, C. H, Watkin, J. G, Molenberghs, G, & Carroll, R. J. (2004). Choice of the primary analysis in longitudinal clinical trials. Pharmaceutical Statistics, 3(3), 161–169
32. McGlashan, T. H, Zipursky, R. B, Perkins, D, Addington, J, Miller, T, Woods, S. W, … Breier, A. (2006). Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry, 163(5), 790–799
33. Meyer, E. C, Carrion, R. E, Cornblatt, B. A, Addington, J, Cadenhead, K. S, Cannon, T. D, … Seifman, L. (2014). The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophrenia Bulletin, 40(6), 1452–1461
34. Miller, T. J, McGlashan, T. H, Woods, S. W, Stein, K, Driesen, N, Corcoran, C. M, … Davidson, L. (1999). Symptom assessment in schizophrenic prodromal states. Psychiatric Quarterly, 70(4), 273–287
35. Montgomery, S. A, & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389
36. Morrison, A. P, French, P, Walford, L, Lewis, S. W, Kilcommons, A, Green, J, … Bentall, R. P. (2004). Cognitive therapy for the prevention of psychosis in people at ultra-high risk randomised controlled trial. The British Journal of Psychiatry, 185(4), 291–297
37. Mueser, K. T, Sayers, S. L, Schooler, N. R, Mance, R. M, & Haas, G. L. (1994). A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms. The American Journal of Psychiatry, 151(10), 1453–1462
38. Nelson, B, Yuen, H. P, Wood, S. J, Lin, A, Spiliotacopoulos, D, Bruxner, A, … Yung, A. R. (2013). Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis: The PACE 400 study. JAMA Psychiatry, 70(8), 793–802
39. O'Brien, M. P, Zinberg, J. L, Ho, L, Rudd, A, Kopelowicz, A, Daley, M, … Cannon, T. D. (2009). Family problem solving interactions and 6-month symptomatic and functional outcomes in youth at ultra-high risk for psychosis and with recent onset psychotic symptoms: A longitudinal study. Schizophrenia Research, 107(2), 198–205
40. Overall, J. E, & Gorhnam, D. R. (1962). The brief psychiatric rating scale. Psychological Reports, 10, 799–812
41. Peralta, V, Cuesta, M. J, & de Leon, J. (1995). Positive and negative symptoms/syndromes in schizophrenia: Reliability and validity of different diagnostic systems. Psychological Medicine, 25(1), 43–50
42. Piskulic, D, Addington, J, Cadenhead, K. S, Cannon, T. D, Cornblatt, B. A, Heinssen, R, … McGlashan, T. H. (2012). Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Research, 196(2–3), 220–224
43. Pruessner, M, Faridi, K, Shah, J, Rabinovitch, M, Iyer, S, Abadi, S, … Mall, A. K. (2015). The Clinic for Assessment of Youth at Risk (CAYR): 10 Years of service delivery and research targeting the prevention of psychosis in Montreal, Canada. Early Intervention in Psychiatry. doi: 10.1111/eip.12300
44. Pruessner, M, Iyer, S. N, Faridi, K, Joober, R, & Malla, A. K. (2011). Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls. Schizophrenia Research, 129(1), 29–35
45. Pukrop, R, & Klosterkotter, J. (2010). Neurocognitive indicators of clinical high-risk states for psychosis: A critical review of the evidence. Neurotoxicity Research, 18(3–4), 272–286
46. Rietdijk, J, Hogerzeil, S. J, van Hemert, A. M, Cuijpers, P, Linszen, D. H, & van der Gaag, M. (2011). Pathways to psychosis: Help-seeking behavior in the prodromal phase. Schizophrenia Research, 132(2–3), 213–219
47. Rietdijk, J, Ising, H. K, Dragt, S, Klaassen, R, Nieman, D, Wunderink, L, … Gaag, M. (2013). Depression and social anxiety in help-seeking patients with an ultra-high risk for developing psychosis. Psychiatry Research, 209(3), 309–313
48. Salokangas, R. K, Ruhrmann, S, von Reventlow, H. G, Heinimaa, M, Svirskis, T, From, T, … Klosterkötter, J. (2012). Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries. Schizophrenia Research, 138(2–3), 192–197
49. Schlosser, D. A, Campellone, T. R, Biagianti, B, Delucchi, K. L, Gard, D. E, Fulford, D, … Vinogradov, S. (2015). Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis. Schizophrenia Research, 169(1), 204–208
50. Schlosser, D. A, Fisher, M, Gard, D, Fulford, D, Loewy, R. L, & Vinogradov, S. (2014). Motivational deficits in individuals at-risk for psychosis and across the course of schizophrenia. Schizophrenia Research, 158(1–3), 52–57
51. Siris, S. G. (2000). Depression in schizophrenia: Perspective in the era of “Atypical” antipsychotic agents. The American Journal of Psychiatry, 157(9), 1379–1389
52. Sonmez, N, Rossberg, J. I, Evensen, J, Barder, H. E, Haahr, U, Ten Velden Hegelstad, W, … Friis, S. (2014). Depressive symptoms in first-episode psychosis: A 10-year follow-up study. Early Intervention in Psychiatry, 10(3), 227–233
53. Vracotas, N, Schmitz, N, Joober, R, & Malla, A. (2007). Subjective distress in first-episode psychosis: Role of symptoms and self-esteem. Early Intervention in Psychiatry, 1(3), 251–258
54. Yung, A. R, Phillips, L. J, Yuen, H. P, Francey, S. M, McFarlane, C. A, Hallgren, M, … McGorry, P. D. (2003). Psychosis prediction: 12-Month follow up of a high-risk (“prodromal”) group. Schizophrenia Research, 60(1), 21–32
55. Yung, A. R, Yuen, H. P, McGorry, P. D, Phillips, L. J, Kelly, D, Dell'Olio, M, … Buckby, J. (2005). Mapping the onset of psychosis: The Comprehensive Assessment of At-Risk Mental States. The Australian and New Zealand Journal of Psychiatry, 39(11–12), 964–971
56. Zaytseva, Y, Korsakova, N, Agius, M, & Gurovich, I. (2013). Neurocognitive functioning in schizophrenia and during the early phases of psychosis: Targeting cognitive remediation interventions. BioMed Research International, 2013, 819587